Hold is still in effect. IMO, can't expect much out of the pps - with any new CEO - while the hold is active. Market needs clarity on how the hold gets resolved and any impacts.
Exactly! An EVP from Amgen would have been spot on at this juncture and for multiple reasons. Or more broadly - how about someone that has a proven track record? How about someone not tied so closely to Sindrasky? How about a heavy hitter from the business world with proven business chops?
That was a nearly impossible question to answer on its face. We'll know more about what KB is capable of following the results of the hold, which will hopefully be soon.